Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Guideline-indicated life-saving medical and device therapies are considerably underutilised in outpatients with heart failure

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Medtronic Inc.New Data Illustrates Variances in the Use of Evidence-Based Heart Failure Treatments. Media Release: 8 Nov 2007. Available from: URL: http://www.medtronic.com

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Guideline-indicated life-saving medical and device therapies are considerably underutilised in outpatients with heart failure. Pharmacoecon. Outcomes News 541, 10 (2007). https://doi.org/10.2165/00151234-200705410-00018

    Download citation

    Keywords

    • Heart Failure
    • Aldosterone
    • Receptor Blocker
    • Cardiac Resynchronisation Therapy
    • American Heart Association